{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:03:31Z","timestamp":1793037811529,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7242102"],"award-info":[{"award-number":["7242102"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.intimp.2024.111999","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T01:58:16Z","timestamp":1712282296000},"page":"111999","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Tacrolimus alleviates pulmonary fibrosis progression through inhibiting the activation and interaction of ILC2 and monocytes"],"prefix":"10.1016","volume":"132","author":[{"given":"Bowen","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1594-9002","authenticated-orcid":false,"given":"Chi","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honggang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.intimp.2024.111999_b0005","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.intimp.2024.111999_b0010","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1183\/09031936.00185114","article-title":"Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review","volume":"46","author":"Hutchinson","year":"2015","journal-title":"Eur Respir J"},{"issue":"9807","key":"10.1016\/j.intimp.2024.111999_b0015","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(11)60052-4","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"King","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.intimp.2024.111999_b0020","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/crj.13466","article-title":"Idiopathic pulmonary fibrosis: current and future treatment","volume":"16","author":"Glass","year":"2022","journal-title":"Clin Respir J"},{"issue":"6","key":"10.1016\/j.intimp.2024.111999_b0025","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.immuni.2018.05.013","article-title":"Innate lymphoid cells: diversity, plasticity, and unique functions in immunity","volume":"48","author":"Colonna","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.111999_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.671966","article-title":"The fate of activated group 2 innate lymphoid cells","volume":"12","author":"Matha","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2024.111999_b0035","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/thoraxjnl-2012-202003","article-title":"IL-25 drives remodelling in allergic airways disease induced by house dust mite","volume":"68","author":"Gregory","year":"2013","journal-title":"Thorax"},{"issue":"337","key":"10.1016\/j.intimp.2024.111999_b0040","doi-asserted-by":"crossref","first-page":"p. 337ra65","DOI":"10.1126\/scitranslmed.aaf1938","article-title":"Combinatorial targeting of TSLP, IL-25, and IL-33 in type 2 cytokine-driven inflammation and fibrosis","volume":"8","author":"Vannella","year":"2016","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.intimp.2024.111999_b0045","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nri.2017.90","article-title":"Type 2 immunity in tissue repair and fibrosis","volume":"18","author":"Gieseck","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2024.111999_b0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12890-017-0380-z","article-title":"Upregulation of interleukin-33 and thymic stromal lymphopoietin levels in the lungs of idiopathic pulmonary fibrosis","volume":"17","author":"Lee","year":"2017","journal-title":"BMC Pulm Med"},{"issue":"7","key":"10.1016\/j.intimp.2024.111999_b0055","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1111\/all.14196","article-title":"TSLP and IL-33 reciprocally promote each other's lung protein expression and ILC2 receptor expression to enhance innate type-2 airway inflammation","volume":"75","author":"Toki","year":"2020","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.intimp.2024.111999_b0060","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2116279119","article-title":"Reciprocal regulation of IL-33 receptor-mediated inflammatory response and pulmonary fibrosis by TRAF6 and USP38","volume":"119","author":"Yi","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.intimp.2024.111999_b0065","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1084\/jem.20162152","article-title":"Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span","volume":"214","author":"Misharin","year":"2017","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.intimp.2024.111999_b0070","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1038\/s41467-020-18466-w","article-title":"IL-33-ST2 axis regulates myeloid cell differentiation and activation enabling effective club cell regeneration","volume":"11","author":"Dagher","year":"2020","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.intimp.2024.111999_b0075","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.jaci.2014.05.011","article-title":"IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice","volume":"134","author":"Li","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.intimp.2024.111999_b0080","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/mi.2017.99","article-title":"Macrophages regulate lung ILC2 activation via Pla2g5-dependent mechanisms","volume":"11","author":"Yamaguchi","year":"2018","journal-title":"Mucosal Immunol"},{"issue":"11","key":"10.1016\/j.intimp.2024.111999_b0085","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.4049\/jimmunol.2100688","article-title":"STAT6-IP-dependent disruption of IL-33-mediated ILC2 expansion and type 2 innate immunity in the murine lung","volume":"209","author":"Moarbes","year":"2022","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.intimp.2024.111999_b0090","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2165\/00003495-200059020-00021","article-title":"Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation","volume":"59","author":"Plosker","year":"2000","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.intimp.2024.111999_b0095","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s10067-015-3065-0","article-title":"The efficacy of tacrolimus in patients with refractory dermatomyositis\/polymyositis: a systematic review","volume":"34","author":"Ge","year":"2015","journal-title":"Clin Rheumatol"},{"issue":"8","key":"10.1016\/j.intimp.2024.111999_b0100","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1002\/art.21240","article-title":"Treatment of antisynthetase-associated interstitial lung disease with tacrolimus","volume":"52","author":"Wilkes","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.intimp.2024.111999_b0105","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X221092374","article-title":"Calcineurin inhibitors in systemic sclerosis - a systematic literature review","volume":"14","author":"Hofmann","year":"2022","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"2","key":"10.1016\/j.intimp.2024.111999_b0110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.autrev.2018.07.013","article-title":"Treatment of idiopathic inflammatory myositis associated interstitial lung disease: a systematic review and meta-analysis","volume":"18","author":"Barba","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.intimp.2024.111999_b0115","doi-asserted-by":"crossref","first-page":"1014462","DOI":"10.3389\/fimmu.2022.1014462","article-title":"Role of FK506-sensitive signals in asthmatic lung inflammation","volume":"13","author":"Tomiaki","year":"2022","journal-title":"Front Immunol"},{"issue":"Pt A","key":"10.1016\/j.intimp.2024.111999_b0120","article-title":"Tacrolimus ameliorates bleomycin-induced pulmonary fibrosis by inhibiting M2 macrophage polarization via JAK2\/STAT3 signaling","volume":"113","author":"Liu","year":"2022","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.intimp.2024.111999_b0125","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00646-2019","article-title":"A spatially restricted fibrotic niche in pulmonary fibrosis is sustained by M-CSF\/M-CSFR signalling in monocyte-derived alveolar macrophages","volume":"55","author":"Joshi","year":"2020","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.intimp.2024.111999_b0130","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/path.5092","article-title":"An ST2-dependent role of bone marrow-derived group 2 innate lymphoid cells in pulmonary fibrosis","volume":"245","author":"Zhao","year":"2018","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.intimp.2024.111999_b0135","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1073\/pnas.1315854111","article-title":"IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis","volume":"111","author":"Hams","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.intimp.2024.111999_b0140","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/intimm\/dxab062","article-title":"Group 2 innate lymphoid cells in bone marrow regulate osteoclastogenesis in a reciprocal manner via RANKL, GM-CSF and IL-13","volume":"33","author":"Momiuchi","year":"2021","journal-title":"Int Immunol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924005174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924005174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:57:09Z","timestamp":1778619429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924005174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":28,"alternative-id":["S1567576924005174"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111999","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tacrolimus alleviates pulmonary fibrosis progression through inhibiting the activation and interaction of ILC2 and monocytes","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111999","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111999"}}